Suppr超能文献

C9orf72 型肌萎缩侧索硬化症无症状携带者和患者的皮质功能

Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.

作者信息

Geevasinga Nimeshan, Menon Parvathi, Nicholson Garth A, Ng Karl, Howells James, Kril Jillian J, Yiannikas Con, Kiernan Matthew C, Vucic Steve

机构信息

Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia.

Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney, New South Wales, Australia.

出版信息

JAMA Neurol. 2015 Nov;72(11):1268-74. doi: 10.1001/jamaneurol.2015.1872.

Abstract

IMPORTANCE

The identification of the chromosome 9 open reading frame 72 (c9orf72) gene hexanucleotide repeat expansion represents a major advance in the understanding of amyotrophic lateral sclerosis (ALS) pathogenesis. The pathophysiological mechanism by which the c9orf72 gene expansion leads to neurodegeneration is not yet elucidated. Cortical hyperexcitability is potentially an important pathophysiological process in sporadic ALS and familial ALS (FALS).

OBJECTIVE

To investigate whether cortical hyperexcitability forms the pathophysiological basis of c9orf72 FALS using the threshold-tracking transcranial magnetic stimulation technique.

DESIGN, SETTING, AND PARTICIPANTS: Prospective case-control single-center study that took place at hospitals and outpatient clinics from January 1, 2013, to January 1, 2015. Clinical and functional assessments along with transcranial magnetic stimulation studies were taken on 15 patients with c9orf72 FALS and 11 asymptomatic expansion carriers of c9orf72 who were longitudinally followed up for 3 years. Results were compared with 73 patients with sporadic ALS and 74 healthy control participants.

MAIN OUTCOMES AND MEASURES

Cortical excitability variables, including short-interval intracortical inhibition, were measured in patients with c9orf72 FALS and results were compared with asymptomatic c9orf72 carriers, patients with sporadic ALS, and healthy control participants.

RESULTS

Mean (SD) short-interval intracortical inhibition was significantly reduced in patients with c9orf72 FALS (1.2% [1.8%]) and sporadic ALS (1.6% [1.2%]) compared with asymptomatic c9orf72 expansion carriers (10.2% [1.8%]; F = 16.1; P < .001) and healthy control participants (11.8% [1.0%]; F = 16.1; P < .001). The reduction of short-interval intracortical inhibition was accompanied by an increase in intracortical facilitation (P < .01) and motor-evoked potential amplitude (P < .05) as well as a reduction in the resting motor threshold (P < .05) and cortical silent period duration (P < .001).

CONCLUSIONS AND RELEVANCE

This study establishes cortical hyperexcitability as an intrinsic feature of symptomatic c9orf72 expansion-related ALS but not asymptomatic expansion carriers.

摘要

重要性

9号染色体开放阅读框72(c9orf72)基因六核苷酸重复序列扩增的鉴定代表了在理解肌萎缩侧索硬化症(ALS)发病机制方面的一项重大进展。c9orf72基因扩增导致神经变性的病理生理机制尚未阐明。皮质兴奋性过高可能是散发性ALS和家族性ALS(FALS)中一个重要的病理生理过程。

目的

使用阈值跟踪经颅磁刺激技术研究皮质兴奋性过高是否构成c9orf72 FALS的病理生理基础。

设计、地点和参与者:2013年1月1日至2015年1月1日在医院和门诊诊所进行的前瞻性病例对照单中心研究。对15例c9orf72 FALS患者和11例c9orf72无症状扩增携带者进行了临床和功能评估以及经颅磁刺激研究,并对其进行了为期3年的纵向随访。将结果与73例散发性ALS患者和74例健康对照参与者进行比较。

主要结局和测量指标

在c9orf72 FALS患者中测量皮质兴奋性变量,包括短间隔皮质内抑制,并将结果与无症状c9orf72携带者、散发性ALS患者和健康对照参与者进行比较。

结果

与无症状c9orf72扩增携带者(10.2%[1.8%];F = 16.1;P <.001)和健康对照参与者(11.8%[1.0%];F = 16.1;P <.001)相比,c9orf72 FALS患者(1.2%[1.8%])和散发性ALS患者(1.6%[1.2%])的平均(标准差)短间隔皮质内抑制显著降低。短间隔皮质内抑制的降低伴随着皮质内易化增加(P <.01)、运动诱发电位幅度增加(P <.05)以及静息运动阈值降低(P <.05)和皮质静息期持续时间缩短(P <.001)。

结论及意义

本研究确定皮质兴奋性过高是有症状的c9orf72扩增相关ALS的一个内在特征,但不是无症状扩增携带者的特征。

相似文献

1
Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.
JAMA Neurol. 2015 Nov;72(11):1268-74. doi: 10.1001/jamaneurol.2015.1872.
2
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.
Brain. 2008 Jun;131(Pt 6):1540-50. doi: 10.1093/brain/awn071. Epub 2008 May 9.
3
Pathophysiological insights into ALS with C9ORF72 expansions.
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):931-5. doi: 10.1136/jnnp-2012-304529. Epub 2013 Mar 5.
4
Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis.
JAMA Neurol. 2015 Jan;72(1):49-57. doi: 10.1001/jamaneurol.2014.2940.
5
Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
Eur J Neurol. 2017 Jun;24(6):816-824. doi: 10.1111/ene.13295. Epub 2017 Apr 24.
6
Cortical contributions to the flail leg syndrome: Pathophysiological insights.
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):389-96. doi: 10.3109/21678421.2016.1145232. Epub 2016 Feb 18.
8
Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.
Muscle Nerve. 2016 Aug;54(2):264-9. doi: 10.1002/mus.25047. Epub 2016 May 25.
9
Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study.
Neurobiol Aging. 2013 Dec;34(12):2890.e7-2890.e12. doi: 10.1016/j.neurobiolaging.2013.06.009. Epub 2013 Jul 17.
10
Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
Exp Neurol. 2009 Nov;220(1):177-82. doi: 10.1016/j.expneurol.2009.08.017. Epub 2009 Aug 28.

引用本文的文献

1
Neurophysiological biomarkers of networks impairment in amyotrophic lateral sclerosis.
J Neurol. 2025 Jul 14;272(8):507. doi: 10.1007/s00415-025-13229-3.
2
Dynamics of Onset and Progression in Amyotrophic Lateral Sclerosis.
Brain Sci. 2025 Jun 3;15(6):601. doi: 10.3390/brainsci15060601.
4
Unveiling amyotrophic lateral sclerosis complexity: insights from proteomics, metabolomics and microbiomics.
Brain Commun. 2025 Mar 19;7(2):fcaf114. doi: 10.1093/braincomms/fcaf114. eCollection 2025.
7
Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS.
Brain Sci. 2024 Jul 29;14(8):760. doi: 10.3390/brainsci14080760.
10
Diagnostic utility of transcranial magnetic stimulation for neurodegenerative disease: a critical review.
Dement Neuropsychol. 2024 Jan 5;17:e20230048. doi: 10.1590/1980-5764-DN-2023-0048. eCollection 2023.

本文引用的文献

2
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.
Lancet Neurol. 2014 Nov;13(11):1108-1113. doi: 10.1016/S1474-4422(14)70219-4. Epub 2014 Oct 7.
3
A zebrafish model exemplifies the long preclinical period of motor neuron disease.
J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1288-9. doi: 10.1136/jnnp-2014-308288. Epub 2014 Jun 26.
4
Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.
Trends Neurosci. 2014 Aug;37(8):433-42. doi: 10.1016/j.tins.2014.05.006. Epub 2014 Jun 11.
5
Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons.
Cell Rep. 2014 Apr 10;7(1):1-11. doi: 10.1016/j.celrep.2014.03.019. Epub 2014 Apr 3.
6
Amyotrophic lateral sclerosis: a long preclinical period?
J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1232-8. doi: 10.1136/jnnp-2013-307135. Epub 2014 Mar 19.
7
RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.
Neuron. 2013 Oct 16;80(2):415-28. doi: 10.1016/j.neuron.2013.10.015.
8
Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.
Neuron. 2013 Aug 7;79(3):416-38. doi: 10.1016/j.neuron.2013.07.033.
10
Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Brain. 2013 May;136(Pt 5):1361-70. doi: 10.1093/brain/awt085.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验